
  
    
      
        Background_NNP
        Follicle_NNP stimulating_VBG hormone_NN (_( FSH_NNP )_) regulates_VBZ
        spermatogenesis_NNS through_IN the_DT somatic_JJ Sertoli_NNP cells_NNS of_IN the_DT
        testis_NNS [_NN 1_CD ]_NN ._. Sertoli_NNP cells_NNS act_VBP as_IN "_'' nursing_NN "_'' cells_NNS and_CC
        supplies_NNS germ_NN cells_NNS with_IN energy_NN and_CC controls_VBZ the_DT
        biochemical_JJ environment_NN in_IN which_WDT they_PRP develop_VBP [_NN 2_CD ]_NN ._. Among_IN
        the_DT FSH-regulated_NNP functions_NNS are_VBP increased_VBN glucose_NN uptake_NN
        and_CC oxidation_NN ._. In_IN response_NN to_TO glucose_NN ,_, transcription_NN of_IN
        several_JJ glycolytic_JJ and_CC lipogenic_JJ genes_NNS are_VBP activated_VBN
        through_IN the_DT glucose_NN /_NN carbohydrate_NN /_NN insulin_NN response_NN element_NN
        (_( GIRE_NNP ,_, ChoRE_NNP or_CC IRE_NNP )_) [_NN 3_CD 4_CD ]_NN ._. Upstream_NNP stimulatory_NN factors_NNS
        (_( USF_NNP )_) 1_CD and_CC 2_CD are_VBP characterized_VBN by_IN a_DT basic_JJ /_NN helix_NN loop_NN
        helix_NN /_NN leucine_NN zipper_NN domain_NN responsible_JJ for_IN dimerization_NN
        and_CC DNA_NNP binding_JJ ,_, and_CC are_VBP major_JJ components_NNS of_IN the_DT GIRE_NNP
        complex_JJ [_NN 5_CD 6_CD 7_CD 8_CD ]_NN ._.
        The_DT main_JJ USF_NNP isoforms_NNS USF_NNP 1_CD (_( 43_CD kDa_NN )_) and_CC USF_NNP 2_CD (_( 44_CD kDa_NN )_)
        are_VBP ubiquitously_RB expressed_VBN and_CC encoded_JJ by_IN separate_JJ genes_NNS [_NN
        9_CD 10_CD 11_CD ]_NN ._. In_IN addition_NN ,_, more_JJR isoforms_NNS of_IN USF_NNP 2_CD are_VBP produced_VBN
        due_JJ to_TO alternative_NN splicing_VBG and_CC utilization_NN of_IN different_JJ
        translation_NN start_NN sites_NNS [_NN 12_CD 13_CD ]_NN ._. USF_NNP factors_NNS exist_VBP as_IN
        homo_NN and_CC heterodimers_NNS ,_, and_CC the_DT heterodimer_NN of_IN USF_NNP 1_CD /_NN USF_NNP 2_CD a_DT
        seems_VBZ to_TO dominate_VB ,_, although_IN there_EX are_VBP cell-type_JJ specific_JJ
        variations_NNS [_NN 12_CD ]_NN ._. USF_NNP 1_CD and_CC USF_NNP 2_CD show_NN different_JJ
        transactivating_VBG potential_JJ ,_, and_CC USF_NNP 2_CD appears_VBZ to_TO be_VB the_DT
        functional_JJ transactivator_NN of_IN the_DT GIRE_NNP complex_NN ,_, although_IN
        both_DT USF_NNP 1_CD and_CC USF_NNP 2_CD are_VBP important_JJ for_IN sustained_VBN
        dietary-induced_JJ expression_NN of_IN the_DT fatty_NN acid_NN synthase_NN gene_NN
        in_IN liver_NN [_NN 14_CD ]_NN ._.
        USF_NNP isoforms_NNS are_VBP important_JJ for_IN expression_NN of_IN several_JJ
        genes_NNS involved_VBN in_IN Sertoli_NNP cell_NN growth_NN and_CC differentiation_NN ._.
        Among_IN genes_NNS that_WDT are_VBP stimulated_VBN by_IN FSH_NNP /_NN cAMP_NN during_IN the_DT
        period_NN of_IN maturation_NN of_IN Sertoli_NNP cells_NNS (_( 15_CD to_TO 20_CD days_NNS of_IN age_NN
        in_IN rats_NNS )_) ,_, are_VBP several_JJ subunits_NNS of_IN cAMP-dependent_JJ protein_NN
        kinase_NN (_( PKA_NNP )_) ,_, the_DT serine_NN /_NN threonine_NN kinase_NN mainly_RB
        responsible_JJ for_IN the_DT downstream_JJ effects_NNS of_IN FSH_NNP [_NN 15_CD ]_NN ._.
        Expression_NNP of_IN the_DT RIIβ_NNP regulatory_JJ subunit_NN of_IN cAMP-dependent_JJ
        protein_NN kinase_NN is_VBZ highly_RB induced_VBN (_( 50_CD -_: fold_VB )_) at_IN the_DT mRNA_NN
        level_NN in_IN primary_JJ cultures_NNS of_IN rat_NN Sertoli_NNP cells_NNS as_IN a_DT late_JJ
        response_NN to_TO cAMP_NN peaking_VBG at_IN 12_CD hours_NNS [_NN 16_CD ]_NN ._. We_PRP have_VBP
        demonstrated_VBN that_DT expression_NN of_IN CAAT_NNP /_NN Enhancer_NNP binding_JJ
        protein_NN β_NN (_( C_NNP /_NN EBPβ_NNP )_) is_VBZ induced_VBN by_IN cAMP_NN with_IN rapid_JJ kinetics_NNS
        in_IN Sertoli_NNP cells_NNS ,_, and_CC that_IN C_NNP /_NN EBPβ_NNP is_VBZ responsible_JJ for_IN
        induction_NN of_IN late_JJ response_NN genes_NNS like_IN the_DT RIIβ-gene_NNP [_NN 17_CD ]_NN
        ._. The_DT RIIβ_NNP promoter_NN contains_VBZ a_DT conserved_JJ E-_NNP box_NN /_NN HLH_NNP element_NN
        in_IN the_DT basal_NN promoter_NN localized_JJ at_IN -_: 280_CD to_TO -_: 275_CD relative_JJ to_TO
        the_DT functional_JJ ATG_NNP [_NN 18_CD ]_NN ._. This_DT element_NN is_VBZ shown_VBN to_TO be_VB
        important_JJ for_IN cAMP-responsiveness_JJ in_IN granulosa_NN cells_NNS ,_, and_CC
        it_PRP has_VBZ been_VBN shown_VBN to_TO bind_NN both_DT USF_NNP and_CC Myc_NNP in_IN CHO_NNP and_CC NB_NNP 2_CD a_DT
        cells_NNS [_NN 18_CD 19_CD ]_NN ._. In_IN this_DT work_NN ,_, we_PRP show_VBP that_IN USF_NNP isoforms_NNS
        may_MD regulate_VB cAMP_NN responsiveness_NNS of_IN the_DT RIIβ_NNP promoter_NN by_IN
        modulating_VBG the_DT effect_NN of_IN C_NNP /_NN EBP_NNP ,_, and_CC that_IN the_DT formation_NN of_IN
        USF_NNP isoforms_NNS may_MD be_VB regulated_VBN by_IN cAMP_NN in_IN Sertoli_NNP cells_NNS ._.
      
      
        Results_NNS
        
          USF_NNP complexes_NNS are_VBP formed_VBN on_IN the_DT RIIβ_NNP
          promoter_NN
          A_DT specific_JJ complex_NN that_WDT formed_VBD a_DT Dnase_NNP I_PRP footprint_NN
          (_( -_: 306_CD to_TO -_: 265_CD )_) in_IN the_DT cAMP-responsive_JJ region_NN of_IN the_DT RIIβ_NNP
          promoter_NN in_IN granulosa_NN cells_NNS [_NN 18_CD ]_NN ,_, covers_VBZ a_DT consensus_NN
          E-_NNP box_NN (_( CACGTG_NNP )_) known_VBN to_TO bind_NN helix-loop-helix_JJ (_( bHLH_NN )_)
          transcription_NN factors_NNS ._. Electrophoretic_NNP mobility_NN shift_NN
          assay_NN (_( EMSA_NNP )_) with_IN extracts_NNS from_IN Sertoli_NNP cells_NNS
          demonstrated_VBD specific_JJ binding_VBG to_TO the_DT conserved_JJ element_NN
          using_VBG the_DT footprinted_JJ region_NN as_IN probe_NN [_NN 20_CD ]_NN ._. When_WRB
          incubated_JJ with_IN proteins_NNS from_IN Sertoli_NNP cell_NN nuclear_JJ
          extracts_NNS at_IN least_JJS five_CD complexes_NNS were_VBD formed_VBN (_( Fig_NNP ._. 1_LS ,_,
          complex_JJ I_PRP to_TO V_NNP )_) ._. We_PRP found_VBD that_IN USF_NNP 2_CD antibody_NN shifted_VBD
          complex_JJ I_PRP and_CC III_NNP (_( Fig_NNP ._. 1_LS lanes_NNS 3_CD and_CC 4_LS )_) ,_, whereas_IN complex_JJ
          II_NNP and_CC IV_NNP were_VBD completely_RB shifted_VBN with_IN USF_NNP 1_CD antibody_NN ,_,
          suggesting_VBG that_IN the_DT USF_NNP complexes_NNS contained_VBD homodimers_NNS ._.
          Complex_JJ V_NNP was_VBD not_RB shifted_VBN by_IN antibodies_NNS directed_VBN against_IN
          N-_NNP terminal_NN parts_NNS of_IN USF_NNP 1_CD or_CC USF_NNP 2_CD ,_, but_CC with_IN antibodies_NNS
          directed_VBN against_IN the_DT C-_NNP terminal_NN DNA-binding_NNP region_NN of_IN
          USF_NNP 2_CD (_( Fig_NNP ._. 1_LS lane_NN 3_LS )_) ._. Thus_RB ,_, this_DT complex_NN contained_VBD
          truncated_JJ USF_NNP 2_CD ._. A_DT small_JJ shift_NN in_IN mobility_NN of_IN this_DT complex_NN
          was_VBD observed_VBN in_IN extracts_NNS prepared_VBN from_IN Sertoli_NNP cells_NNS
          treated_VBN with_IN 8_CD -_: CPT-cAMP_NNP for_IN 6_CD h_NN (_( data_NNS not_RB shown_VBN )_) ._.
          Experiments_NNS using_VBG various_JJ protease_NN inhibitors_NNS indicated_VBD
          that_IN the_DT changes_NNS in_IN complex_JJ mobility_NN were_VBD due_JJ to_TO
          inhibitory_NN effects_NNS of_IN PKA_NNP on_IN the_DT protease_NN calpain_NN ._. The_DT
          truncated_JJ USF_NNP complexes_NNS forming_VBG complexes_NNS III_NNP to_TO IV_NNP were_VBD
          abolished_VBN in_IN the_DT presence_NN of_IN calpain_NN inhibitor_NN I_PRP (_( ALLN_NNP )_)
          (_( unpublished_JJ results_NNS )_) ._.
        
        
          A_DT 31_CD -_: kDa_NN USF_NNP 1_CD isoform_NN is_VBZ induced_VBN by_IN cAMP_NN
          In_IN order_NN to_TO study_VB the_DT existence_NN of_IN different_JJ variants_NNS
          of_IN USF_NNP expressed_VBD under_IN stimulated_VBN and_CC basal_NN conditions_NNS ,_,
          we_PRP performed_VBD immunoblotting_VBG experiments_NNS with_IN antibodies_NNS
          against_IN C-_NNP terminal_NN regions_NNS of_IN USF_NNP 1_CD and_CC USF_NNP 2_CD ._. For_IN USF_NNP 1_CD ,_, we_PRP
          observed_VBD that_IN a_DT new_JJ immunoreactive_JJ protein_NN of_IN about_IN 31_CD
          kDa_NN was_VBD formed_VBN only_RB in_IN nuclear_JJ extracts_NNS from_IN
          cAMP-stimulated_JJ Sertoli_NNP cells_NNS (_( Fig_NNP ._. 2_LS A_DT )_) ._. This_DT isoform_NN was_VBD
          not_RB soluble_JJ ,_, but_CC associated_VBN with_IN a_DT 1_CD %_NN Triton_NNP extractable_JJ
          fraction_NN (_( not_RB shown_VBN )_) ._. In_IN contrast_NN ,_, we_PRP found_VBD no_DT
          significant_JJ changes_NNS in_IN USF_NNP 2_CD protein_NN levels_NNS or_CC mobility_NN
          following_VBG stimulation_NN by_IN cAMP_NN (_( Fig_NNP ._. 2_LS B_NNP )_) ._. Other_JJ truncated_JJ
          USF_NNP 1_CD or_CC USF_NNP 2_CD isoforms_NNS could_MD not_RB be_VB detected_VBN in_IN this_DT
          assay_NN ,_, which_WDT may_MD indicate_VB that_IN the_DT levels_NNS of_IN isoforms_NNS
          forming_VBG complex_JJ V_NNP (_( Fig_NNP ._. 1_LS )_) are_VBP very_RB low_JJ relative_NN to_TO the_DT
          full-length_JJ protein_NN ._. We_PRP were_VBD not_RB able_JJ to_TO relate_VB the_DT
          appearance_NN of_IN the_DT novel_NN 31_CD kDa_NN USF_NNP 1_CD isoform_NN to_TO changes_NNS in_IN
          USF_NNP complex_JJ formation_NN in_IN EMSA_NNP ._. Formation_NNP of_IN the_DT truncated_JJ
          USF_NNP 1_CD isoform_NN in_IN cAMP-treated_JJ cells_NNS was_VBD not_RB affected_VBN by_IN
          addition_NN of_IN calpain_NN inhibitor_NN (_( unpublished_JJ results_NNS )_) ._.
        
        
          USF_NNP 2_CD inhibits_NNS cAMP-mediated_JJ induction_NN of_IN the_DT RIIβ_NNP
          promoter_NN
          We_PRP investigated_VBD the_DT function_NN of_IN USF_NNP isoforms_NNS in_IN
          regulation_NN of_IN the_DT RIIβ_NNP promoter_NN ,_, using_VBG a_DT CAT_NNP reporter_NN
          containing_VBG the_DT basal_NN RIIβ_NNP promoter_NN including_VBG the_DT
          consensus_NN E-_NNP box_NN (_( Fig_NNP ._. 3_LS A_DT )_) and_CC expression_NN vectors_NNS for_IN
          USF_NNP 1_CD ,_, USF_NNP 2_CD a_DT and_NN USF_NNP 2_CD b_SYM isoforms_NNS ._. We_PRP found_VBD that_DT none_NN of_IN the_DT
          USF_NNP isoforms_NNS affected_VBD basal_NN transcription_NN from_IN the_DT RIIβ_NNP
          promoter_NN (_( not_RB shown_VBN )_) whereas_IN both_DT splice_NN variants_NNS of_IN USF_NNP 2_CD
          (_( a_DT and_NN b_SYM )_) reduced_VBN cAMP-stimulated_JJ levels_NNS of_IN reporter_NN
          expression_NN to_TO 25_CD %_NN ._. USF_NNP 1_CD ,_, however_RB ,_, had_VBD no_DT inhibitory_NN
          effect_NN on_IN the_DT cAMP-mediated_JJ induction_NN of_IN RIIβ_NNP ._. Fig_NNP ._.
          3_LS Bshows_NNP a_DT dose-dependent_JJ reduction_NN of_IN cAMP_NN responsiveness_NNS
          with_IN increasing_VBG amounts_NNS of_IN USF_NNP 2_CD a_DT expression_NN vector_NN with_IN a_DT
          50_CD %_NN reduction_NN in_IN reporter_NN activity_NN at_IN 75_CD ng_NN of_IN USF_NNP 2_CD a_DT
          vector_NN and_CC a_DT 75_CD %_NN inhibition_NN at_IN 750_CD ng_NN of_IN USF_NNP 2_CD a_DT
          vector_NN ._.
        
        
          USF_NNP 2_CD inhibits_NNS C_NNP /_NN EBP-mediated_NNP induction_NN of_IN the_DT RIIβ_NNP
          promoter_NN
          We_PRP have_VBP previously_RB reported_VBN that_IN some_DT of_IN the_DT late_JJ
          induction_NN of_IN RIIβ_NNP by_IN cAMP_NN depends_VBZ on_IN the_DT rapid_JJ
          cAMP-mediated_JJ increase_NN in_IN C_NNP /_NN EBPβ_NNP expression_NN [_NN 17_CD ]_NN ._. To_TO
          test_VB the_DT effect_NN of_IN different_JJ USF_NNP isoforms_NNS on_IN
          C_NNP /_NN EBPβ-mediated_NNP induction_NN of_IN the_DT RIIβ_NNP promoter_NN ,_, we_PRP
          transfected_JJ combinations_NNS of_IN the_DT transcription_NN factors_NNS
          (_( Fig_NNP ._. 4_LS )_) ._. As_IN previously_RB reported_VBN ,_, the_DT full-length_JJ
          LAP-form_NNP of_IN C_NNP /_NN EBPβ_NNP induced_VBD the_DT RIIβ_NNP promoter_NN 5_CD -_: 6_CD -_: fold_VB ,_,
          whereas_IN the_DT C_NNP /_NN EBPβ_NNP LIP-form_NNP lacking_VBG the_DT transactivating_VBG
          region_NN had_VBD no_DT effect_NN ._. Co-transfecting_NNP USF_NNP 1_CD had_VBD no_DT
          significant_JJ effect_NN on_IN C_NNP /_NN EBPβ-mediated_NNP induction_NN ,_, but_CC
          USF_NNP 2_CD a_DT (_( 1_CD :_: 1_CD ,_, USF_NNP 2_CD a_SYM :_: C_NNP /_NN EBPβ_NNP expression_NN vectors_NNS )_) reduced_VBN
          induction_NN by_IN 60_CD %_NN ,_, indicating_VBG that_IN USF_NNP 2_CD a_DT may_MD interrupt_VB the_DT
          ability_NN of_IN C_NNP /_NN EBPβ_NNP to_TO transactivate_NN the_DT RIIβ_NNP promoter_NN ._.
        
      
      
        Discussion_NNP
        The_DT promoters_NNS of_IN several_JJ genes_NNS induced_VBN by_IN FSH_NNP in_IN Sertoli_NNP
        cells_NNS and_CC granulosa_NN cells_NNS ,_, including_VBG c-_NN Fos_NNP ,_, transferrin_NN ,_,
        follicle_NN stimulating_VBG hormone_NN receptor_NN ,_, SF-_NNP 1_CD genes_NNS and_CC the_DT
        RIIβ_NNP gene_NN ,_, contain_VB functional_JJ E-_NNP box_NN elements_NNS [_NN 21_CD 22_CD 23_CD 24_CD
        ]_NN ._. We_PRP found_VBD that_IN several_JJ USF_NNP complexes_NNS containing_VBG
        full-length_JJ USF_NNP 1_CD and_CC USF_NNP 2_CD as_RB well_RB as_IN truncated_JJ versions_NNS ,_,
        are_VBP formed_VBN at_IN the_DT consensus_NN E-_NNP box_NN /_NN HLH-binding_NNP element_NN in_IN
        the_DT RIIβ_NNP promoter_NN in_IN Sertoli_NNP cell_NN nuclear_JJ extracts_NNS ._.
        USF_NNP 1_CD and_CC USF_NNP 2_CD display_NN identical_JJ dimerization_NN and_CC DNA_NNP
        binding_JJ domains_NNS ,_, but_CC the_DT transactivating_VBG regions_NNS differ_VBP [_NN
        25_CD ]_NN ._. USF_NNP 1_CD and_CC USF_NNP 2_CD obviously_RB serve_VB different_JJ ,_, yet_RB
        overlapping_VBG functions_NNS ,_, and_CC regulating_VBG the_DT relative_JJ
        USF_NNP 1_CD /_NN USF_NNP 2_CD levels_NNS may_MD be_VB decisive_JJ for_IN the_DT pattern_NN of_IN
        USF-mediated_NNP gene_NN expression_NN ,_, which_WDT has_VBZ been_VBN shown_VBN in_IN
        studies_NNS of_IN USF_NNP knockout_NN mice_NNS ._. The_DT USF_NNP 2_CD -_: /_NN -_: mouse_NN has_VBZ
        obvious_JJ growth_NN defects_NNS and_CC reduced_VBN fertility_NN [_NN 25_CD ]_NN ,_,
        whereas_IN the_DT USF_NNP 1_CD -_: deficient_NN mice_NNS are_VBP viable_JJ and_CC fertile_JJ with_IN
        minor_JJ behavioural_NN disturbances_NNS ._. A_DT severe_JJ delay_NN in_IN
        glucose-mediated_JJ regulation_NN of_IN the_DT GIRE-containing_NNP fatty_NN
        acid_NN synthase_NN (_( FAS_NNP )_) gene_NN is_VBZ found_VBN in_IN both_DT USF-deficient_NNP
        mice_NNS ,_, although_IN insulin_NN response_NN was_VBD unaltered_JJ ,_, indicating_VBG
        that_IN the_DT USF_NNP 1_CD /_NN USF_NNP 2_CD heterodimer_NN is_VBZ implicated_VBN in_IN FAS_NNP
        expression_NN [_NN 14_CD ]_NN ._.
        We_PRP have_VBP previously_RB shown_VBN that_IN C_NNP /_NN EBPβ_NNP functions_NNS as_IN a_DT
        secondary_JJ effector_NN of_IN cAMP_NN signaling_VBG on_IN slow_JJ response_NN genes_NNS
        in_IN Sertoli_NNP cells_NNS ,_, including_VBG RIIβ_NNP [_NN 17_CD ]_NN ._. Both_DT C_NNP /_NN EBP_NNP and_CC
        the_DT RIIβ_NNP E-_NNP box_NN is_VBZ shown_VBN be_VB involved_VBN in_IN cAMP_NN responsiveness_NNS
        of_IN the_DT RIIβ_NNP gene_NN [_NN 17_CD 18_CD ]_NN ._.
        Our_PRP$ present_JJ results_NNS indicate_VBP that_IN USF_NNP 2_CD disturbs_VBZ this_DT
        C_NNP /_NN EBPβ-mediated_NNP transactivation_NN of_IN RIIβ_NNP ._. No_DT consensus_NN
        C_NNP /_NN EBPβ_NNP binding_JJ site_NN is_VBZ found_VBN in_IN the_DT promoter_NN construct_VB
        responsive_JJ to_TO cAMP_NN and_CC C_NNP /_NN EBPβ_NNP ,_, but_CC a_DT possibility_NN exists_VBZ
        that_IN C_NNP /_NN EBPβ_NNP attach_VBP to_TO the_DT RIIβ_NNP promoter_NN through_IN
        protein_NN /_NN protein_NN interactions_NNS with_IN USF_NNP 1_CD or_CC other_JJ members_NNS of_IN
        the_DT transcriptional_NN unit_NN formed_VBN at_IN the_DT E-_NNP box_NN ._. C_NNP /_NN EBP_NNP is_VBZ
        previously_RB reported_VBN to_TO be_VB an_DT important_JJ accessory_JJ factor_NN for_IN
        transactivation_NN by_IN several_JJ other_JJ transcription_NN factors_NNS [_NN 26_CD
        ]_NN ._. C_NNP /_NN EBPβ_NNP was_VBD shown_VBN to_TO transactivate_NN the_DT α_NN 1_CD -_: acid_NN
        glycoprotein_NN gene_NN promoter_NN even_RB when_WRB mutated_VBN in_IN the_DT
        DNA-binding_NNP domain_NN ,_, and_CC this_DT activation_NN appeared_VBD to_TO depend_VB
        on_IN protein-protein_JJ interaction_NN with_IN glucocorticoid_NN receptor_NN
        through_IN the_DT leucine_NN zipper_NN region_NN [_NN 27_CD ]_NN ._. Recently_RB ,_, a_DT
        conserved_JJ domain_NN in_IN C_NNP /_NN EBPα_NNP and_CC C_NNP /_NN EBPβ_NNP was_VBD shown_VBN to_TO mediate_VB
        cAMP_NN responsiveness_NNS ,_, strengthening_VBG the_DT fact_NN that_IN C_NNP /_NN EBP_NNP may_MD
        be_VB characterized_VBN as_IN a_DT cAMP-responsive_JJ nuclear_JJ regulator_NN [_NN
        28_CD 29_CD ]_NN ._. On_IN the_DT COX-_NNP 2_CD promoter_NN in_IN granulosa_NN cells_NNS ,_,
        cAMP-mediated_JJ regulation_NN was_VBD shown_VBN to_TO be_VB mediated_JJ primarily_RB
        by_IN an_DT E-_NNP box_NN that_DT bind_NN USF_NNP 1_CD and_CC USF_NNP 2_CD isoforms_NNS in_IN a_DT manner_NN
        resembling_VBG the_DT RIIβ_NNP E-_NNP box_NN in_IN Sertoli_NNP cells_NNS [_NN 30_CD ]_NN ._.
        Transactivation_NNP of_IN the_DT COX-_NNP 2_CD gene_NN in_IN skin_NN carcinoma_NN cells_NNS
        is_VBZ highly_RB dependent_JJ on_IN this_DT E-_NNP box_NN together_RB with_IN a_DT C_NNP /_NN EBP_NNP
        binding_JJ site_NN that_DT bind_NN C_NNP /_NN EBPβ_NNP and_CC C_NNP /_NN EBPδ_NNP [_NN 31_CD ]_NN ._. These_DT
        data_NNS strengthens_VBZ a_DT model_NN of_IN formation_NN of_IN a_DT cAMP-responsive_JJ
        unit_NN (_( CRU_NNP )_) containing_VBG USF_NNP and_CC C_NNP /_NN EBP_NNP ._. We_PRP propose_VBP a_DT model_NN of_IN
        interaction_NN between_IN USF_NNP and_CC C_NNP /_NN EBPβ_NNP by_IN which_WDT USF_NNP 2_CD inhibits_NNS
        the_DT cAMP_NN responsiveness_NNS of_IN C_NNP /_NN EBPβ_NNP ,_, either_CC through_IN
        interacting_VBG with_IN the_DT domain_NN mediating_VBG the_DT cAMP_NN
        responsiveness_NNS or_CC by_IN competing_VBG with_IN USF_NNP 1_CD ._.
        The_DT cAMP-regulated_JJ formation_NN of_IN a_DT 31_CD -_: kDa_NN USF_NNP 1_CD isoform_NN
        may_MD also_RB play_VB a_DT role_NN in_IN formation_NN of_IN the_DT RIIβ_NNP CRU_NNP ._. This_DT
        truncated_JJ USF_NNP 1_CD isoform_NN may_MD result_VB from_IN proteolytic_JJ cleavage_NN
        or_CC may_MD be_VB a_DT novel_NN splice_NN variant_NN ._. In_IN granulosa_NN cells_NNS ,_, it_PRP
        has_VBZ previously_RB been_VBN shown_VBN that_IN the_DT level_NN of_IN N-_NNP terminally_RB
        truncated_JJ USF_NNP 2_CD is_VBZ regulated_VBN by_IN cAMP_NN ._. Binding_NNP of_IN truncated_JJ
        USF_NNP 2_CD to_TO a_DT HLH_NNP element_NN in_IN the_DT prostaglandin_NN G_NNP /_NN H_NNP synthase_NN 2_CD
        (_( PGHS-_NNP 2_LS )_) promoter_NN was_VBD abolished_VBN in_IN extracts_NNS from_IN cells_NNS
        stimulated_VBN by_IN human_JJ chorionic_JJ gonadotrophin_NN (_( hCG_NN )_) which_WDT
        signals_NNS through_IN cAMP_NN [_NN 32_CD ]_NN ._.
        Other_JJ reports_NNS have_VBP suggested_VBN a_DT role_NN for_IN USF_NNP in_IN
        inhibition_NN of_IN transcriptional_NN activation_NN mediated_JJ by_IN other_JJ
        transcription_NN factors_NNS ._. An_DT inhibitory_NN effect_NN of_IN USF_NNP on_IN
        Myc-mediated_NNP cellular_JJ proliferation_NN has_VBZ been_VBN demonstrated_VBN
        in_IN HeLa_NNP cells_NNS [_NN 33_CD ]_NN ,_, and_CC a_DT non-canonical_JJ HLH_NNP element_NN
        inhibits_NNS expression_NN of_IN the_DT fibroblast_NN growth_NN factor_NN binding_JJ
        protein_NN (_( FGF-BP_NNP )_) in_IN several_JJ carcinoma_NN cells_NNS [_NN 34_CD ]_NN ._.
        Furthermore_RB ,_, USF_NNP 2_CD inhibits_NNS binding_JJ of_IN hypoxia-inducible_JJ
        factor-_NN 1_CD (_( HIF-_NNP 1_LS )_) to_TO the_DT plasminogen_NN activator_NN inhibitor_NN -_: 1_CD
        (_( PAI-_NNP 1_LS )_) gene_NN in_IN hepatocytes_NNS in_IN order_NN to_TO disturb_VB
        transcriptional_NN activation_NN [_NN 35_CD ]_NN ._. Our_PRP$ results_NNS add_VBP
        C_NNP /_NN EBPβ-mediated_NNP activation_NN of_IN RIIβ_NNP to_TO the_DT mechanisms_NNS
        inhibited_VBD by_IN USF_NNP ._. An_DT opposite_JJ role_NN of_IN USF_NNP and_CC C_NNP /_NN EBP_NNP could_MD
        also_RB be_VB explained_VBN by_IN the_DT counteracting_VBG effects_NNS these_DT
        transcription_NN factors_NNS have_VBP on_IN glucose_NN metabolism_NN ._. Whereas_IN
        USF_NNP induces_VBZ expression_NN of_IN enzymes_NNS involved_VBN in_IN glycolysis_NNS ,_,
        C_NNP /_NN EBPβ_NNP regulates_VBZ gluconeogenesis_NNS mainly_RB by_IN activating_VBG
        phosphoenolpyruvate_NN carboxykinase_NN (_( PEPCK_NNP )_) [_NN 36_CD 37_CD ]_NN ._.
        It_PRP has_VBZ recently_RB been_VBN reported_VBN that_IN USF_NNP is_VBZ implicated_VBN in_IN
        transcriptional_NN activation_NN of_IN the_DT 1_CD a_DT promoter_NN of_IN the_DT RIα_NNP
        gene_NN in_IN skeletal_NN muscle_NN cells_NNS [_NN 38_CD ]_NN ._. Regulating_NNP the_DT
        relative_JJ levels_NNS of_IN RIα_NNP versus_CC RIIβ_NNP is_VBZ physiologically_RB
        important_JJ eg_NN ._. in_IN lipid_NN metabolism_NN [_NN 39_CD 40_CD ]_NN ,_, and_CC a_DT
        possible_JJ function_NN of_IN USF_NNP in_IN tuning_VBG RIα_NNP /_NN RIIβ_NNP ratio_NN by_IN
        activating_VBG RIα_NNP transcription_NN and_CC inhibiting_VBG RIIβ_NNP
        transcription_NN is_VBZ an_DT interesting_JJ target_NN of_IN further_JJ
        investigation_NN ._.
      
      
        Conclusions_NNP
        1_LS ._. USF_NNP 1_CD and_CC USF_NNP 2_CD ,_, as_RB well_RB as_IN truncated_JJ USF_NNP isoforms_NNS ,_,
        bind_NN to_TO a_DT consensus_NN E-_NNP box_NN in_IN the_DT RIIβ_NNP promoter_NN in_IN Sertoli_NNP
        cells_NNS ._.
        2_LS ._. Cyclic_NNP AMP_NNP induces_VBZ expression_NN of_IN a_DT novel_NN 31_CD -_: kDa_NN USF_NNP 1_CD
        isoform_NN ._.
        3_LS ._. Overexpression_NNP of_IN USF_NNP 2_CD ,_, but_CC not_RB USF_NNP 1_CD ,_, inhibits_NNS
        cAMP-mediated_JJ and_CC C_NNP /_NN EBPβ-mediated_NNP induction_NN of_IN the_DT RIIβ_NNP
        promoter_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Antibodies_NNP
          USF_NNP antibodies_NNS specific_JJ for_IN USF_NNP 1_CD amino_JJ acids_NNS 83_CD to_TO 157_CD
          (_( USF_NNP 1_CD N_NNP )_) ,_, USF_NNP 2_CD a_DT amino_JJ acids_NNS 1_CD to_TO 49_CD (_( USF_NNP 2_CD N_NNP )_) and_CC USF_NNP 2_CD a_DT /_NN b_SYM
          amino_JJ acids_NNS 298_CD to_TO 346_CD (_( USF_NNP 2_CD C_NNP )_) [_NN 12_CD ]_NN ._.
        
        
          Preparation_NNP and_CC stimulation_NN of_IN cell_NN cultures_NNS
          Primary_JJ cultures_NNS of_IN rat_NN Sertoli_NNP cells_NNS were_VBD made_VBN from_IN
          testes_NNS of_IN 19_CD days_NNS old_JJ Sprague-_NNP Dawley_NNP rats_NNS (_( B_NNP &_CC K_NNP
          Universal_NNP AS_NNP ,_, Nittedal_NNP ,_, Norway_NNP )_) according_VBG to_TO the_DT method_NN
          of_IN Dorrington_NNP 
          et_CC al_NN ._. with_IN some_DT modifications_NNS [_NN 41_CD
          ]_NN ._. Culturing_NNP and_CC transfections_NNS were_VBD performed_VBN as_IN
          described_VBN elsewhere_RB [_NN 42_CD ]_NN ._. Two_CD days_NNS after_IN
          transfections_NNS ,_, the_DT medium_NN was_VBD changed_VBN ,_, and_CC incubation_NN was_VBD
          continued_VBN in_IN the_DT presence_NN or_CC absence_NN of_IN 100_CD μM_NN
          8_CD -_: (_( 4_CD -_: chlorophenyl_NN )_) thio-c_JJ AMP_NNP (_( 8_CD -_: CPT-cAMP_NNP )_) (_( Sigma_NNP ,_, St_NNP
          Louis_NNP ,_, MO_NNP )_) ._.
        
        
          Preparation_NNP of_IN nuclear_JJ extracts_NNS
          Nuclear_NNP extract_VB from_IN Sertoli_NNP cells_NNS (_( 12_CD ×_NN 10_CD 6_CD )_) were_VBD
          prepared_VBN by_IN solubilization_NN of_IN nuclei_NN in_IN 0_CD ._. 4_CD M_NNP NaCl_NNP as_IN
          described_VBN previously_RB [_NN 17_CD ]_NN ._.
        
        
          DNA-Protein_NNP complex_JJ analysis_NN
          Electrophoretic_NNP mobility_NN shift_NN assays_NNS (_( EMSAs_NNP )_) were_VBD
          performed_VBN using_VBG a_DT double_RB stranded_VBN [_NN 32_CD P_NN ]_NN -_: end-labeled_JJ
          oligonucleotide_NN covering_VBG the_DT consensus_NN E-_NNP box_NN /_NN HLH_NNP element_NN
          (_( underlined_VBD )_) and_CC flanking_VBG sequences_NNS from_IN the_DT RIIβ_NNP
          promoter_NN (_( -_: 305_CD ,_, 5_CD '_POS -_: GATCGCCGGGTTGCCATGGTTT_NNP CCGGGGAT_NNP
          CACGTGGGCGCGCGG-_NNP 3_CD '_POS ,_, -_: 268_CD )_) ._. For_IN each_DT reaction_NN ,_, 5_CD ×_NN 10_CD 3_CD cpm_NN
          of_IN labeled_VBN probe_NN was_VBD incubated_JJ with_IN 5_CD μg_NN of_IN crude_NN nuclear_JJ
          proteins_NNS from_IN Sertoli_NNP cells_NNS and_CC 1_CD ._. 0_CD μg_NN of_IN poly_RB dI_NN :_: dC_NN in_IN a_DT
          buffer_NN containing_VBG 5_CD mM_NN Hepes_NNP pH_NN 7_CD ._. 9_CD ,_, 26_CD %_NN glycerol_NN ,_, 0_CD ._. 2_CD
          mM_NN EDTA_NNP ,_, 0_CD ._. 5_CD mM_NN DTT_NNP ,_, 0_CD ._. 5_CD mM_NN PMSF_NNP ,_, 150_CD mM_NN KCl_NNP and_CC 5_CD mM_NN
          MgCl_NNP at_IN room_NN temperature_NN for_IN 15_CD min_NN ._. Supershift_NNP
          experiments_NNS were_VBD performed_VBN by_IN incubation_NN of_IN nuclear_JJ
          extract_NN /_NN DNA_NNP with_IN 2_CD μl_NN USF_NNP antibodies_NNS for_IN 30_CD min_NN at_IN 4_CD °_NN C_NNP ._.
          Samples_NNP were_VBD run_VBN in_IN 6_CD %_NN non-denaturing_JJ polyacrylamide_NN
          gels_NNS at_IN 120_CD -_: 150_CD V_NNP in_IN Tris-glycine_NNP buffer_NN (_( 50_CD mM_NN Tris_NNP pH_NN
          8_CD ._. 5_CD ,_, 380_CD mM_NN glycine_NN ,_, 2_CD mM_NN EDTA_NNP )_) for_IN 3_CD to_TO 5_CD h_NN at_IN 4_CD °_NN C_NNP ._.
          Subsequently_RB ,_, gels_NNS were_VBD dried_VBN and_CC subjected_VBN to_TO
          autoradiography_NN ._.
        
        
          Immunoblotting_NNP
          20_CD μg_NN of_IN nuclear_JJ extract_NN from_IN Sertoli_NNP cell_NN were_VBD loaded_VBN
          in_IN 10_CD %_NN SDS_NNP PAGE_NNP gels_NNS and_CC immunoblotting_VBG was_VBD performed_VBN as_RB
          previously_RB described_VBD [_NN 42_CD ]_NN ._. Equal_NNP loading_NN was_VBD
          determined_VBN by_IN coomassie_NN staining_VBG ._.
        
        
          Plasmids_NNP
          A_DT reporter_NN construct_VB containing_VBG the_DT basal_NN promoter_NN of_IN
          the_DT rat_NN RIIβ_NNP 5_CD '_POS -_: flanking_VBG region_NN (_( -_: 394_CD to_TO -_: 123_CD )_) upstream_RB
          of_IN a_DT CAT-reporter_NNP gene_NN (_( pCATbasic_JJ ;_: Promega_NNP ,_, Madison_NNP ,_, WI_NNP )_)
          was_VBD used_VBN for_IN assaying_VBG RIIβ_NNP promoter_NN activity_NN [_NN 18_CD ]_NN ._.
          Expression_NNP vectors_NNS for_IN USF_NNP 1_CD ,_, USF_NNP 2_CD a_DT and_NN USF_NNP 2_CD b_SYM inserted_VBN 3_CD '_POS
          of_IN the_DT CMV_NNP promoter_NN in_IN pCR_NN ™_NN 3_CD (_( Invitrogen_NNP ,_, Groningen_NNP ,_, The_DT
          Netherlands_NNP )_) were_VBD used_VBN to_TO overexpress_NNS USF_NNP isoforms_NNS [_NN 12_CD ]_NN
          ._. C_NNP /_NN EBPβ_NNP LAP_NNP (_( full-length_JJ )_) and_CC LIP_NNP (_( DNA-binding_NNP domain_NN )_)
          expression_NN vectors_NNS created_VBN in_IN pCMV_NN ™_NN 3_CD (_( Stratagene_NNP ,_, La_NNP
          Jolla_NNP ,_, CA_NNP )_) were_VBD appreciated_VBN gifts_NNS from_IN Dr_NNP ._. Shizua_NNP Akira_NNP
          (_( Hyogo_NNP College_NNP of_IN Medicine_NNP ,_, Hyogo_NNP ,_, Japan_NNP )_) ._. The_DT luciferase_NN
          expression_NN vector_NN pGL_NN 3_CD Control_NNP (_( 0_CD ._. 25_CD μg_NN )_) (_( Promega_NNP ,_,
          Madison_NNP ,_, WI_NNP )_) was_VBD used_VBN as_IN an_DT internal_JJ marker_NN for_IN
          transfection_NN efficiency_NN ._.
        
        
          Transfections_NNP ,_, Luciferase-_NNP and_CC CAT-assays_NNP
          After_IN 2_CD days_NNS of_IN culture_NN in_IN serum_NN free_JJ medium_NN ,_,
          lipofectamine-mediated_JJ transfections_NNS of_IN primary_JJ cultures_NNS
          of_IN rat_NN Sertoli_NNP cells_NNS were_VBD performed_VBN (_( 2_CD μg_NN DNA_NNP per_IN well_RB in_IN
          6_CD -_: well_RB plates_NNS )_) and_CC assayed_JJ as_IN described_VBN by_IN Grønning_NNP et_CC al_NN
          [_NN 17_CD ]_NN ._.
        
      
      
        List_NN of_IN abbreviations_NNS
        C_NNP ;_: catalytic_JJ subunit_NN ,_, cAMP_NN ;_: cyclic_JJ adenosine_NN
        monophosphate_NN ,_, CAT_NNP ;_: chloramphenicol_NN acetyl_NN transferase_NN ,_,
        C_NNP /_NN EBP_NNP ;_: CAAT_NNP /_NN enhancer_NN binding_JJ protein_NN ,_, ChoRE_NNP ;_: carbohydrate_NN
        response_NN element_NN ,_, CMV_NNP ;_: cytalomega_NN virus_NN ,_, 8_CD -_: CPT-cAMP_NNP ;_:
        8_CD -_: (_( 4_CD -_: chlorophenyl_NN )_) thio-c_JJ AMP_NNP ,_, CREB_NNP ;_: cAMP-response_JJ element_NN
        binding_JJ protein_NN ,_, EMSA_NNP ;_: electrophoretic_JJ mobility_NN shift_NN
        assay_NN ,_, FAS_NNP ;_: fatty_NN acid_NN synthase_NN ,_, FSH_NNP ;_: follicle_NN stimulating_VBG
        hormone_NN ,_, GIRE_NNP ;_: glucose_NN /_NN insulin_NN response_NN element_NN ,_, hCG_NN ;_: human_JJ
        chorionic_JJ gonadotrophin_NN ,_, HLH_NNP ;_: helix-loop-helix_JJ ,_, IRE_NNP ;_:
        insulin_NN response_NN element_NN ,_, MHC_NNP ;_: major_JJ histocompability_NN
        complex_JJ ,_, PGHS_NNP ;_: prostaglandin_NN G_NNP /_NN H_NNP synthase_NN ,_, PKA_NNP ;_:
        cAMP-dependent_JJ protein_NN kinase_NN ,_, R_NN ;_: regulatory_JJ subunit_NN ,_, USF_NNP ;_:
        upstream_RB stimulating_VBG factor_NN ,_, WB_NNP ;_: Western_JJ blot_NN ._.
      
      
        Authors_NNP '_'' contributions_NNS
        Maria_NNP K_NNP ._. Dahle_NNP (_( author_NN 1_LS )_) performed_VBD the_DT EMSA_NNP and_CC
        expression_NN experiments_NNS and_CC drafted_VBD the_DT manuscript_NN ._. Kjetil_NNP
        Taskén_NNP (_( author_NN 2_LS )_) participated_VBD in_IN the_DT design_NN and_CC
        coordination_NN of_IN the_DT study_NN ._. Kristin_NNP A_DT ._. Taskén_NNP (_( author_NN 3_LS )_)
        initialized_JJ ,_, planned_VBN and_CC coordinated_VBN the_DT study_NN ,_, performed_VBD
        the_DT immunoblotting_VBG and_CC contributed_VBD to_TO all_DT experiments_NNS ._. All_DT
        authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
